Sunmax Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced total revenue was TWD 77.693 million compared to TWD 48.071 million a year ago. Sales was TWD 77.693 million compared to TWD 48.071 million a year ago. Operating income was TWD 17.090 million compared to operating loss of TWD 774,000 a year ago. Net income was TWD 13.723 million compared to TWD 4.086 million a year ago. Basic earnings per share was TWD 0.25 compared to TWD 0.08 a year ago. For the nine months, total revenue was TWD 205.374 million compared to TWD 136.749 million a year ago. Sales was TWD 205.374 million compared to TWD 136.749 million a year ago. Operating income was TWD 35.661 million compared to TWD 8.688 million a year ago. Net income was TWD 44.763 million compared to TWD 11.656 million a year ago. Basic earnings per share was TWD 0.83 compared to TWD 0.22 a year ago.